Search
for
Sort by
Research 61–90 of 1000+
- Screening: seeking a balance
- Total prostate volume as risk factor for semen pathologies in ageing male
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Prostate cancer update: 2007
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Finasteride-its impact on sexual function and prostate cancer
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Finasteride in Androgenic Alopecia
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Editorial Comment
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Economic Issues in the Treatment of BPH
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Is Dihydrotestosterone a Classic Hormone?